Spero Therapeutics Inc (SPRO) Event July 01, 2022, 20:06 UTC 9 1 comments (99% Neutral) SPERO THERAPEUTICS, INC. (SPRO) Announces Executive Changes Comment Full text
Genmab (GMAB) Event July 01, 2022, 16:23 UTC 8 1 comments (99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K) Comment Full text
AstraZeneca (AZN) Event July 01, 2022, 14:00 UTC 10 1 comments (99% Neutral) AstraZeneca (AZN) Files Form 6-K Comment Full text
Centessa Pharmaceuticals plc (CNTA) Event July 01, 2022, 12:45 UTC 11 1 comments (75% Positive) CENTESSA PHARMACEUTICALS PLC (CNTA) Announces Clinical Development Update Comment Full text
KemPharm Inc (the company was transformed to Zevra (NASDAQ GS: ZVRA)) (KMPH) Event July 01, 2022, 12:32 UTC 11 1 comments (99% Neutral) KemPharm, Inc. (KMPH) Files Form 8-K Comment Full text
Evelo Biosciences, Inc. (EVLO) Event July 01, 2022, 10:58 UTC 11 1 comments (35% Negative) EVELO BIOSCIENCES, INC. (EVLO) Announces Business Combination Comment Full text
Amarin Corporation Plc (AMRN) Event June 30, 2022, 21:20 UTC 12 1 comments (99% Neutral) AMARIN CORP PLC\UK (AMRN) Announces Regulatory Update Comment Full text
Geron Corporation Inc (GERN) Event June 30, 2022, 21:15 UTC 11 1 comments (70% Positive) GERON CORPORATION (GERN) Reports Q2 2022 Financial Results Comment Full text
Talaris Therapeutics Inc (TALS) Event June 30, 2022, 20:54 UTC 11 1 comments (10% Negative) TALARIS THERAPEUTICS, INC. (TALS) Announces Delay in reflected Development Timeline Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
MaxCyte Inc (MXCT) Event June 30, 2022, 20:44 UTC 11 1 comments (99% Neutral) MaxCyte, Inc. (MXCT) Announces Executive Changes Comment Full text